Clinical Trials Directory

Trials / Completed

CompletedNCT05982665

Effect of Inhaled Molecular Hydrogen on Recovery Process After Downhill Walking on the Treadmill

Effect of Inhaled Molecular Hydrogen on Recovery Process After Downhill Walking on the Treadmill. A Randomized, Double-blind, Placebo-controlled Crossover Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Palacky University · Academic / Other
Sex
Male
Age
20 Years – 35 Years
Healthy volunteers
Accepted

Summary

This study assesses the effect of molecular hydrogen inhalation in healthy males on muscle soreness, fatigue, oxidative stress, and inflammation following eccentric muscle contraction during downhill walking on the treadmill.

Detailed description

The main aim of this randomized, double-blind, placebo-controlled crossover study is to assess the effect of molecular hydrogen inhalation on recovery after downhill walking with an additional load of 15% of body mass on the treadmill with a negative slope of -15% at a speed of 6.5 km/h for 90 min. The study includes 12 participants, healthy males aged 20-35 years. The study consists of two experimental sessions, one using molecular hydrogen inhalation and the other using placebo inhalation. Randomization is performed using a computer random generator. Molecular hydrogen is colourless, odourless, and tasteless, so it cannot be distinguished from placebo by the human senses. The washout period between sessions is set at four weeks. One week before each session, participants are asked to follow diet and physical activity rules. Variables measured during the 48 h recovery are as follow: creatine kinase level, perceived muscle soreness, reactive strength index, malondialdehydes level, and interleukin-6 level. The following variables are also measured during exercise: heart rate, ventilation and gas exchange, and blood lactate level. Analysis of variance for repeated measures and Fisher's post hoc tests are used for statistical analysis. The significance level is set at 0.05.

Conditions

Interventions

TypeNameDescription
OTHERMolecular hydrogenHydrogen gas, purity \>99.9%, flow rate 300 ml/min.
OTHERPlaceboAmbient air, flow rate 300 ml/min.

Timeline

Start date
2023-08-14
Primary completion
2023-11-29
Completion
2023-11-29
First posted
2023-08-08
Last updated
2023-12-01

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT05982665. Inclusion in this directory is not an endorsement.